Skip to Main Content

Paper Details

IL-13 is a driver of COVID-19 severity.
JCI Insight
108
2021
Author NameAffiliation
Tara E SutherlandLydia Becker Institute of Immunology and Inflammation, University of Manchester
Chelsea Marie
Saskia PreissnerCharite - Universitatsmedizin Berlin, Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Benjamin T BradleyUniversity of Washington
Jeffrey M Sturek
Jennie Z MaUniversity of Virginia School of Medicine
Gregory Brett Moreau
Jeffrey R Donowitz
Jeffrey R DonowitzChildren's Hospital of Richmond and.
Gregory A BuckVirginia Commonwealth University
Myrna G SerranoVirginia Commonwealth University
Stacey L Burgess
Mayuresh M Abhyankar
Cameron MuraSchool of Data Science and Department of Biomedical Engineering University of Virginia
Philip E BourneSchool of Data Science and Department of Biomedical Engineering University of Virginia
Philip E BourneSchool of Data Science and Department of Biomedical Engineering University of Virginia
Robert PreissnerScience-IT and Institute of Physiology, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Johanna LoombaIntegrated Translational Health Research Institute (iTHRIV) and.
Sarah J Ratcliffe (CM4AI)University of Virginia School of Medicine
Melinda D PoulterUniversity of Virginia School of Medicine
Amy J Mathers
Amy J MathersUniversity of Virginia School of Medicine
Barbara J Mann
Barbara J MannUniversity of Virginia School of Medicine
Judith E AllenLydia Becker Institute of Immunology and Inflammation, University of Manchester
Judith E AllenUniversity of Manchester
William A Petri
William A PetriUniversity of Virginia School of Medicine
William A PetriUniversity of Virginia School of Medicine
  • 1 - 29

Datasets

Release 1.2